Home » ETF » KURE

KURE - KraneShares MSCI All China Health Care Index ETF

Stock Price: $40.33 USD 0.67 (1.69%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
Assets $221.48M
NAV $39.55
Expense Ratio 0.65%
PE Ratio 36.58
Beta (5Y) 0.61
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Dec 27, 2019
1-Year Return -
Trading Day April 21
Last Price $40.33
Previous Close $39.66
Change ($) 0.67
Change (%) 1.69%
Day's Open 40.00
Day's Range 39.87 - 40.49
Day's Volume 70,783
52-Week Range 24.80 - 47.69

Fund Description

The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index (the underlying index). The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, including American depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the healthcare sector. The fund is non-diversified.

Asset Class
Equity
Inception Date
Feb 1, 2018
Exchange
NYSEARCA
Ticker Symbol
KURE
Index Tracked
MSCI China All Shares Health Care 10/40 Index

Top 10 Holdings

43.98% of assets
NameSymbolWeight
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S2269.HK9.08%
Jiangsu Hengrui Medicine Co Ltd600276.SS6.07%
Shenzhen Mindray Bio-Medical Electronics Co Ltd300760.SZ5.21%
BeiGeneBGNE3.96%
Wuxi AppTec Co Ltd Class A603259.SS3.92%
Chongqing Zhifei Biological Products Co Ltd300122.SZ3.61%
Alibaba Health Information Technology Ltd241.HK3.14%
Aier Eye Hospital Group Co Ltd300015.SZ3.05%
CSPC Pharmaceutical Group Ltd1093.HK3.05%
Sino Biopharmaceutical Ltd1177.HK2.89%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 29, 2020$0.00Dec 31, 2020
Dec 27, 2019$0.057Dec 31, 2019
Dec 26, 2018$0.039Dec 28, 2018
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

In the United States, healthcare is a dynamic sector home to defensive value stocks, disruptive growth names, and plenty of in-between. China offers a comparable level of healthcare dynamism, which inve...

2 weeks ago - ETF Trends

The best pharmaceutical ETFs for Q2 2021 are KURE, MJJ, and POTX.

Other tickers mentioned: POTX
2 months ago - Investopedia

The markets rallied because Biden started his term by signing a number of executive orders to counter the ill effects of the COVID-19 pandemic, empower environmental protection initiatives and roll back...

Other tickers mentioned: ACWI, CNRG, HERD, ITB, KWEB, REMX
2 months ago - Zacks Investment Research

The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.

Other tickers mentioned: ARKG, PTH
5 months ago - Investopedia

The best pharmaceutical ETFs for Q1 2021 are KURE, XPH, and IHE.

Other tickers mentioned: IHE, XPH
5 months ago - Investopedia

Chinese stocks have biggest gains in 3 months

YouTube video

Yahoo Finance's Tom Belger reports on the latest stock news from China and Europe.

Other tickers mentioned: CNXT, KWEB
6 months ago - Yahoo Finance

Emerging markets have been hit hard by coronavirus, but some were hit harder than others.

Other tickers mentioned: ASHR, CNYA, EMQQ, EWT, EWY, KWEB
6 months ago - ETFcom

The best healthcare ETFs for Q4 2020 are ARKG, KURE, and PTH.

Other tickers mentioned: ARKG, PTH
8 months ago - Investopedia

The best pharmaceutical ETFs for Q4 2020 are KURE, XPH, and PJP.

Other tickers mentioned: PJP, XPH
8 months ago - Investopedia

Sector ETFs and industry funds are different. The 11 sectors addressed in the S&P 500 are as follows (in order of weight in the index): technology, healthcare, consumer discretionary, communication serv...

Other tickers mentioned: CHIQ, FTEC, ITEQ, ONLN, PSCH, PSCT, SRVR ...
9 months ago - InvestorPlace

The Chinese economy returned to growth in the second quarter of 2020. This along with PBOC's targeted policy easing and China's solid tech industry make China investing winners in the recent trading ses...

Other tickers mentioned: ASHS, CHIS, CNXT
9 months ago - Zacks Investment Research

A host of China ETFs outperformed in June. These funds come mainly from the technology, healthcare and clean energy segments.

Other tickers mentioned: CHIH, CHIK, CQQQ, KGRN, KWEB
9 months ago - Zacks Investment Research

Between the novel coronavirus and an election year, these healthcare ETFs appear poised to post strong growth into 2021.

Other tickers mentioned: ARKG, FHLC, IHI, PTH, RYH, XHE
9 months ago - InvestorPlace

In theory, blaming the emerging markets malaise on China because the country was the initial epicenter of the coronavirus appears to make sense. However, that argument doesn't hold water because the MSC...

Other tickers mentioned: CHIC, EMQQ, EWT, FRDM, GREK, KWEB
9 months ago - InvestorPlace

While most the countries' stocks have been beaten down badly in the pandemic, some still managed to trade in green for the first half of the year.

Other tickers mentioned: EDEN, IZRL
9 months ago - Zacks Investment Research

The fund hit a 52-week high lately. Can this go further higher?

10 months ago - Zacks Investment Research

Overall, the S&P 500, the Dow Jones, the Nasdaq Composite and the Russell 2000 added 4.8%, 5.6%, 1.6%, and 7.9% last week, respectively.

Other tickers mentioned: CLIX, ESPO, HERD, HERO, RING
10 months ago - Zacks Investment Research

The best pharmaceutical ETFs for Q3 2020 are KURE, XPH, and PPH.

Other tickers mentioned: PPH, XPH
11 months ago - Investopedia

The best Healthcare ETFs for Q3 2020 are ARKG, KURE, and PTH.

Other tickers mentioned: ARKG, PTH
11 months ago - Investopedia

Healthcare stocks and ETFs are outperforming the broader market this year, but as the KraneShares MSCI All China Health Care Indes ETF (KURE) proves, that theme isn’t confined to the U.S. KURE invests i...

11 months ago - ETF Trends

Don't ignore healthcare stocks because 2020 is an election year. Some of these funds are poised for big upside.

Other tickers mentioned: ARKG, IHF, PSCH, SBIO, XHE, XLV
11 months ago - InvestorPlace

As stock markets rallied higher Monday after consolidation and pullback over the last couple of days, one ETF was making some considerable moves on the foreign asset front as well.

1 year ago - ETF Trends

Despite being the epicenter of the coronavirus, China ETFs held up pretty well in the first quarter.

Other tickers mentioned: CBON, CHIH, CHIK, CHIS, CNY, CYB, KCNY ...
1 year ago - Zacks Investment Research

These international ETFs have outperformed the S&P 500 in the first quarter.

Other tickers mentioned: EFAV, FDNI, FPXI, IMTM
1 year ago - Zacks Investment Research

Over the past several weeks, China stocks and ETFs have been surprisingly sturdy as the coronavirus appears to be contained there at least for.

1 year ago - ETF Trends

These sector ETFs gained or lost the least in the coronavirus-induced rout in February.

Other tickers mentioned: CLIX, GLD, IDNA, SGDM
1 year ago - Zacks Investment Research

There has been plenty of talk about how China ETFs may perform when the COVID-19 virus is officially put to rest, but there are some examples of some of those ETFs displaying strength in a challenging e...

1 year ago - ETF Trends

ETF Trends CEO Tom Lydon discussed the KraneShares MSCI All China Health Care Indes ETF (KURE) on this week’s “ETF of the Week” podcast with Chuck Jaffe on the MoneyLife Show.

1 year ago - ETF Trends

The best pharmaceutical ETFs for Q1 2020 are KURE, CHIH, and CHNA.

Other tickers mentioned: CHIH, CHNA
1 year ago - Investopedia

The best Healthcare ETFs for Q1 2020 are BBC, SBIO, and KURE.

Other tickers mentioned: BBC, SBIO
1 year ago - Investopedia

China ETFs delivered decent performance in the year of the pig. What would the year of the rat bring?

Other tickers mentioned: ASHS, CHIK, CNXT, KGRN, SPY
1 year ago - Zacks Investment Research

It's not unusual for an emerging markets exchange traded fund to use exclusionary tactics. What is unusual is when an emerging market ETF offering access to multiple developing economies excludes China,...

Other tickers mentioned: KGRN
2 years ago - Benzinga